Companies/Canopy Growth Corporation

Company profile

Canopy Growth Corporation

NASDAQ: CGC · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Smiths Falls, ONCIK 0001737927Reports USD

#284 of 1,394 Healthcare companies by revenue73rd-percentile growth

EA Score

60C

FH 55DQ 59GM 69SS 73

v0.1 · 65/100 weight · provisional

↑ workforce scale, 3-yr revenue growth · ↓ Altman-Z, disclosure history

Methodology →

Revenue TTM

$225.8M

Rev growth YoY (TTM)

+16.8%

Net income (FY)

-$190.2M

Employees

1,029

Market cap

$422.2M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$205.9M284.6M CAD2026

Net income-$190.2M-262.9M CAD2026

Operating income-$117.0M-161.7M CAD2026

Total assets$802.6M1.1B CAD2026

Liabilities$302.1M421.1M CAD2026

Equity$500.5M697.6M CAD2026

Revenue trend

FY2026 – FY2026 · USD

$48.9M

FY26

$94.9M

FY26

$148.9M

FY26

$193.3M

FY25

$51.7M

FY26

$99.3M

FY26

$152.6M

FY26

$205.9M

FY26

Revenue by segment

Filed disclosures · FY2025

By product

Other Revenue0%

By geography

CANADA65%

GERMANY22%

USA10%

Other Geographical Area3%

The read

Canopy Growth Corporation booked $205.9M in FY2026 revenue, growing 35% year over year — faster than most Healthcare companies we track, at a -92.4% net margin.

Peers · Healthcare

Puma Biotechnology, Inc.72B Rocket Pharmaceuticals, Inc.54D Verano Holdings Corp59C Cross Country Healthcare, Inc.67B

Key facts

CEOLuc Mongeau

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersSmiths Falls, ON

ExchangeNASDAQ: CGC

Employees1,029

IPO date2014-04-07

Latest filings

10-K2026-06-15 8-K2026-06-15 8-K2026-05-27 8-K2026-05-15 8-K2026-03-16 10-Q2026-02-06 8-K2026-02-06 8-K2026-01-08

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.